Listed by the USPTO as FRONDA, CHRISTIAN L
Tech Center 1600 • Art Units: 1645 1652 1656
This examiner grants 82% of resolved cases
FRONDA, CHRISTIAN L has resolved 1371 cases in Tech Center 1600 and Art Unit 1645. The profile reports an 82.5% allowance rate and a median of 888 days to allowance. The 14.3% interview lift supports including examiner interviews in the response plan, while the allowance rate indicates that written prosecution remains an important foundation for favorable outcomes.
The listed companies include Novozymes A/S, Ketoneaid Inc., and Alteogen Inc. The representative firms are FOLEY & LARDNER LLP, STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., and SUGHRUE MION, PLLC. The large resolved-case record provides substantial context, and the median timeline calls for active management despite the favorable allowance profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19051360 | MICROORGANISM HAVING INCREASED ACTIVITY OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE, AND USE THEREOF | Non-Final OA | CJ CheilJedang Corporation |
| 19023584 | METHODS TO MANIPULATE QUALITY ATTRIBUTES OF POLYPEPTIDES PRODUCED IN CHO CELLS | Non-Final OA | BRISTOL-MYERS SQUIBB COMPANY |
| 18319864 | ENGINEERED THERMOPHILIC REVERSE TRANSCRIPTASE | Final Rejection | 10x Genomics, Inc. |
| 18739532 | DETERGENT COMPOSITIONS CONTAINING ENZYMES | Non-Final OA | The Procter & Gamble Company |
| 18398165 | Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates | Final Rejection | The Regents of the University of California |
| 18886300 | PLATFORM OF COMPOSABLE MAMMALIAN ELEMENTS OF TRANSCRIPTION (COMET) | Non-Final OA | Northwestern University |
| 18847406 | ALPHA-AMYLASE VARIANT | Non-Final OA | KAO CORPORATION |
| 18000892 | METHOD FOR PRODUCING FORMIC ACID USING CARBON MONOXIDE DEHYDROGENASE AND FORMATE DEHYDROGENASE | Non-Final OA | UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) |
| 18026807 | ALPHA-AMYLASE VARIANTS | Final Rejection | DANSTAR FERMENT AG |
| 19019935 | PROCESSES FOR PRODUCING ETHANOL | Non-Final OA | NOVOZYMES A/S |
| 18956701 | POLYPEPTIDES HAVING LYSOZYME ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES AND COMPOSITIONS THEREOF | Non-Final OA | Novozymes A/S |
| 18896095 | STABILIZED CELLULASE VARIANTS | Non-Final OA | Novozymes A/S |
| 18246060 | METHOD FOR IMPROVING THE STABILITY OF A COMPOSITION COMPRISING A FLAVIN-DEPENDENT LACTATE DEHYDROGENASE | Final Rejection | KIKKOMAN CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy82.5% of resolved applications examined by Christian L Fronda were allowed (1,371 resolved cases), compared with 49.5% across Art Unit 1645 over the last five years.
This examiner's interview lift is +14.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Christian L Fronda took 888 days on average from filing to allowance.
Christian L Fronda examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
